During the past decade, Saskatoon Cancer Centre conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 107 clinical trials were completed, i.e. on average, 135.4% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 43 clinical trials were completed. i.e. 215% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saskatoon Cancer Centre" #1 sponsor was "Children's Oncology Group" with 91 trials, followed by "Radiation Therapy Oncology Group" with 46 trials sponsored, "National Cancer Institute (NCI)" with 35 trials sponsored, "NCIC Clinical Trials Group" with 31 trials sponsored and "Canadian Cancer Trials Group" with 31 trials sponsored. Other sponsors include 94 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saskatoon Cancer Centre" #1 collaborator was "National Cancer Institute (NCI)" with 180 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Eastern Cooperative Oncology Group" with 15 trials as a collaborator and "NCIC Clinical Trials Group" with 14 trials as a collaborator. Other collaborators include 174 different institutions and companies that were collaborators in the rest 100 trials.

According to Clinical.Site data, the most researched conditions in "Saskatoon Cancer Centre" are "Prostate Cancer" (23 trials), "Breast Cancer" (19 trials), "Sarcoma" (19 trials), "Lymphoma" (17 trials) and "Colorectal Cancer" (12 trials). Many other conditions were trialed in "Saskatoon Cancer Centre" in a lesser frequency.

Most popular intervention types in "Saskatoon Cancer Centre" are "Drug" (247 trials), "Radiation" (120 trials), "Other" (91 trials), "Biological" (78 trials) and "Procedure" (71 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (55 trials), "Laboratory Biomarker Analysis" (52 trials), "Cyclophosphamide" (32 trials), "filgrastim" (28 trials) and "Vincristine Sulfate" (26 trials). Other intervention names were less common.

The vast majority of trials in "Saskatoon Cancer Centre" are 260 trials for "All" genders, 33 trials for "Female" genders and 29 trials for "Male" genders.

Currently, there are NaN active trials in "Saskatoon Cancer Centre". 1 are not yet recruiting, 32 are recruiting, 73 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 192 completed trials in Saskatoon Cancer Centre, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Saskatoon Cancer Centre, 14 "Phase 1" clinical trials were conducted, 112 "Phase 2" clinical trials and 170 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".